Bioaffinity Technologies, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bioaffinity Technologies, Inc. (Nasdaq: BIAF) on January 4, 2023. The company is incorporated in Delaware and operates as an emerging growth company. The report covers a specific corporate event occurring on the filing date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The primary material event reported is the issuance of a Notice of Allowance by the U.S. Patent and Trademark Office (USPTO) for the Company's patent application. This event was announced via a press release on January 4, 2023.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard disclosures associated with the patent allowance. The press release detailing the patent is incorporated by reference as Exhibit 99.1.
Investor Verification Checklist
- Verify the specific scope and claims of the patent application approved by the USPTO by reviewing Exhibit 99.1 (Press Release).
- Confirm the trading status of Common Stock (BIAF) and Tradeable Warrants (BIAFW) on The Nasdaq Stock Market LLC.
- Review subsequent filings for any financial impact or commercialization plans related to the newly allowed patent.